The global healthcare landscape is rapidly shifting towards digital health solutions and AI-driven diagnostics to combat escalating medical costs and address physician shortages. There's a critical demand for objective, rapid diagnostic tools, especially in emergency and pediatric care, where timely intervention is paramount. Regulatory bodies are also increasingly supportive of AI in medicine, creating a fertile environment for technologies that improve diagnostic accuracy and operational efficiency, thereby enhancing patient outcomes and optimizing resource allocation.
Reduces Diagnosis Time by 2/3: By automatically analyzing EEG time-series data with AI, this technology significantly streamlines the diagnostic process compared to conventional visual diagnosis by physicians, enabling rapid decision-making in emergency medical settings.
Achieves Over 90% Objective Discrimination Accuracy: Quantitatively analyzing EEG frequency band power values and spatio-temporal correlation coefficients eliminates diagnostic subjectivity, enabling high-precision discrimination between status epilepticus-type acute encephalopathy and febrile seizures.
Strong Patent Scope and High Reliability: This patent was granted after overcoming office actions and comparison with six prior art documents, indicating a stable and robust scope. Involvement of a strong patent agent further objectively validates its strength.
This patent protects a diagnostic support system utilizing EEG time-series data for frequency analysis and multi-faceted feature extraction, including spatio-temporal correlation coefficients, to differentiate acute encephalopathy. It was granted after successfully overcoming an office action with precise arguments and amendments, indicating a robust and stable scope with low invalidation risk.
This patent primarily covers EEG-based diagnostic support. White space exists in integrating this AI with other biosignal analysis (e.g., EMG, EKG), developing therapeutic interventions based on early diagnosis, or expanding into non-neurological diagnostic applications.
Early diagnosis of status epilepticus-type acute encephalopathy could reduce the risk of sequelae, thereby curbing healthcare costs associated with long-term hospitalization and rehabilitation. For example, assuming 300 patients annually incur an additional ~$33.5K (AI est.) in medical expenses due to sequelae from delayed diagnosis, this technology's early diagnosis could avert 10% of these costs, leading to an estimated annual healthcare saving of ~$1.0M (300 patients × ~$33.5K × 10%) (AI est.).
X: Potential for Early Intervention
Y: Diagnostic Objectivity & Accuracy